ORETON METHYL Drug Patent Profile
✉ Email this page to a colleague
When do Oreton Methyl patents expire, and when can generic versions of Oreton Methyl launch?
Oreton Methyl is a drug marketed by Schering and is included in one NDA.
The generic ingredient in ORETON METHYL is methyltestosterone. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oreton Methyl
A generic version of ORETON METHYL was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
Summary for ORETON METHYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 4,818 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORETON METHYL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ORETON METHYL
US Patents and Regulatory Information for ORETON METHYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | ORETON METHYL | methyltestosterone | TABLET;ORAL | 003158-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | ORETON METHYL | methyltestosterone | TABLET;ORAL | 003158-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |